Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saswati Chatterjee

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|June 1, 2026
Adversarial Robust Federated Learning for Secure Mortality Risk Prediction using Multi-Institutional Electronic Health Records (EHRs)Saswati Chatterjee, Suneeta Satpathy
Human Gene Therapy|April 8, 2020
Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic MedicinesSaswati Chatterjee, Venkatesh Sivanandam, Kamehameha Kai-Min Wong
Frontiers in Genome Editing|January 31, 2022
The Role of Recombinant AAV in Precise Genome EditingSwati Bijlani, Ka Ming Pang, Venkatesh Sivanandam, et al.
Human Gene Therapy Methods|May 23, 2012
A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virusCameron Mroske, Hector Rivera, Taihra Ul-Hasan, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2003
Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytesJi-Yao Sun, David Senitzer, Stephen J Forman, et al.
Frontiers in Genome Editing|March 18, 2024
Nuclease-free precise genome editing corrects MECP2 mutations associated with Rett syndromeSwati Bijlani, Ka Ming Pang, Lakshmi V Bugga, et al.
Human Gene Therapy|July 20, 2007
Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transductionHelicia Paz, Christie A Wong, Wei Li, et al.
Human Gene Therapy|May 22, 2010
Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2M Ariel Kauss, Laura J Smith, Li Zhong, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2005
Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient miceLeah Santat, Helicia Paz, Christie Wong, et al.
Cancer Research|May 31, 2002
Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitroJi-Yao Sun, Robert S Krouse, Stephen J Forman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|June 1, 2026
Adversarial Robust Federated Learning for Secure Mortality Risk Prediction using Multi-Institutional Electronic Health Records (EHRs)Saswati Chatterjee, Suneeta Satpathy
Human Gene Therapy|April 8, 2020
Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic MedicinesSaswati Chatterjee, Venkatesh Sivanandam, Kamehameha Kai-Min Wong
Frontiers in Genome Editing|January 31, 2022
The Role of Recombinant AAV in Precise Genome EditingSwati Bijlani, Ka Ming Pang, Venkatesh Sivanandam, et al.
Human Gene Therapy Methods|May 23, 2012
A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virusCameron Mroske, Hector Rivera, Taihra Ul-Hasan, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2003
Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytesJi-Yao Sun, David Senitzer, Stephen J Forman, et al.
Frontiers in Genome Editing|March 18, 2024
Nuclease-free precise genome editing corrects MECP2 mutations associated with Rett syndromeSwati Bijlani, Ka Ming Pang, Lakshmi V Bugga, et al.
Human Gene Therapy|July 20, 2007
Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transductionHelicia Paz, Christie A Wong, Wei Li, et al.
Human Gene Therapy|May 22, 2010
Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2M Ariel Kauss, Laura J Smith, Li Zhong, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2005
Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient miceLeah Santat, Helicia Paz, Christie Wong, et al.
Cancer Research|May 31, 2002
Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitroJi-Yao Sun, Robert S Krouse, Stephen J Forman, et al.
Pageof 2